Investors Hub Daily
iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Hot on StockWiki
My Image Gallery
Medical - Drugs
Neurogenesis Inc (NEUN)
This coming up under neun - is this
Post New Msg
Thursday, June 02, 2011 2:25:42 PM
This coming up under neun - is this the same company?
Neuronascent Receives State and Federal Funding for Its Neurogenesis Therapeutic
CLARKSVILLE, MD, Jun 02, 2011 (MARKETWIRE via COMTEX) -- Neuronascent, Inc.
announced today that the Company has received funding from both the federal
government, under the Qualifying Therapeutic Discovery Project for the
development of its preclinical therapeutic candidates for neurodegenerative
diseases, and from Maryland's Biotechnology Center, to accelerate development of
its neurogenic candidate for Down syndrome. The latter project is a collaboration
with Dr. Barbara Slusher, Chief Scientific Officer, Johns Hopkins University's
NeuroTranslational Brain Center.
Neuronascent aims to develop non-invasive therapeutics for central nervous system
indications with high unmet need. The company's lead compounds, currently in
preclinical testing, are developed to regenerate neurons and provide specialized
neuroprotection for newly generated and surviving neurons under neurodegenerative
diseases. These potentially disease-modifying effects aim to improve behavioral
outcomes including motor function and memory. Animal studies with these compounds
have previously shown a reversal of cognitive loss in aged mice to young levels.
"These funds will allow us to provide proof-of-principle that our neurogenic
therapeutic may be effective for Down syndrome, a new target for drug
development," said Judith Kelleher-Andersson, Ph.D., President and Chief
Scientific Officer. "These funds also afford us the opportunity to pursue
multiple preclinical studies to further develop our lead agents for clinical
trials in Alzheimer's and Parkinson's disease."
Founded in 2004 by Dr. Kelleher-Andersson, Neuronascent, Inc. is a small-molecule
central nervous system drug discovery company, developing novel therapeutics
using their neurogenesis discovery platform. Neuronascent has laboratories in
Rockville and Frederick, Maryland.
For more information contact: firstname.lastname@example.org
Safe Harbor Statement This release contains forward-looking statements, which are
made pursuant to the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. Forward-looking statements are commonly identified
by words such as "would," "may," "will," "expects," and other terms with similar
meaning. Forward-looking statements are based on current beliefs, assumptions and
expectations and speak only as of the date of this release and involve risks and
uncertainties that could cause actual results to differ materially from current
SOURCE: Neuronascent, Inc.
Copyright 2011 Marketwire, Inc., All rights reserved.
Neurogenesis Inc (NEUN) Stock Trading Info:
Post New Msg
Report TOS Violation
+/- to Watchlist
© 2013 InvestorsHub.Com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App